408 related articles for article (PubMed ID: 10802667)
1. Mice deficient in Six5 develop cataracts: implications for myotonic dystrophy.
Klesert TR; Cho DH; Clark JI; Maylie J; Adelman J; Snider L; Yuen EC; Soriano P; Tapscott SJ
Nat Genet; 2000 May; 25(1):105-9. PubMed ID: 10802667
[TBL] [Abstract][Full Text] [Related]
2. Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts.
Sarkar PS; Appukuttan B; Han J; Ito Y; Ai C; Tsai W; Chai Y; Stout JT; Reddy S
Nat Genet; 2000 May; 25(1):110-4. PubMed ID: 10802668
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the expression of DMPK and SIX5 in the human eye and implications for pathogenesis in myotonic dystrophy.
Winchester CL; Ferrier RK; Sermoni A; Clark BJ; Johnson KJ
Hum Mol Genet; 1999 Mar; 8(3):481-92. PubMed ID: 9949207
[TBL] [Abstract][Full Text] [Related]
4. Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities.
Seznec H; Agbulut O; Sergeant N; Savouret C; Ghestem A; Tabti N; Willer JC; Ourth L; Duros C; Brisson E; Fouquet C; Butler-Browne G; Delacourte A; Junien C; Gourdon G
Hum Mol Genet; 2001 Nov; 10(23):2717-26. PubMed ID: 11726559
[TBL] [Abstract][Full Text] [Related]
5. Effect of triplet repeat expansion on chromatin structure and expression of DMPK and neighboring genes, SIX5 and DMWD, in myotonic dystrophy.
Frisch R; Singleton KR; Moses PA; Gonzalez IL; Carango P; Marks HG; Funanage VL
Mol Genet Metab; 2001; 74(1-2):281-91. PubMed ID: 11592825
[TBL] [Abstract][Full Text] [Related]
6. Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy.
Mahadevan MS; Yadava RS; Yu Q; Balijepalli S; Frenzel-McCardell CD; Bourne TD; Phillips LH
Nat Genet; 2006 Sep; 38(9):1066-70. PubMed ID: 16878132
[TBL] [Abstract][Full Text] [Related]
7. Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2.
Ranum LP; Day JW
Curr Neurol Neurosci Rep; 2002 Sep; 2(5):465-70. PubMed ID: 12169228
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of myogenesis in transgenic mice expressing the human DMPK 3'-UTR.
Storbeck CJ; Drmanic S; Daniel K; Waring JD; Jirik FR; Parry DJ; Ahmed N; Sabourin LA; Ikeda JE; Korneluk RG
Hum Mol Genet; 2004 Mar; 13(6):589-600. PubMed ID: 14734627
[TBL] [Abstract][Full Text] [Related]
9. Identification of transcriptional targets for Six5: implication for the pathogenesis of myotonic dystrophy type 1.
Sato S; Nakamura M; Cho DH; Tapscott SJ; Ozaki H; Kawakami K
Hum Mol Genet; 2002 May; 11(9):1045-58. PubMed ID: 11978764
[TBL] [Abstract][Full Text] [Related]
10. Deconstructing myotonic dystrophy.
Tapscott SJ
Science; 2000 Sep; 289(5485):1701-2. PubMed ID: 11001736
[TBL] [Abstract][Full Text] [Related]
11. Transgenic mouse models for myotonic dystrophy type 1 (DM1).
Wansink DG; Wieringa B
Cytogenet Genome Res; 2003; 100(1-4):230-42. PubMed ID: 14526185
[TBL] [Abstract][Full Text] [Related]
12. Skeletal muscle Na currents in mice heterozygous for Six5 deficiency.
Mistry DJ; Moorman JR; Reddy S; Mounsey JP
Physiol Genomics; 2001 Aug; 6(3):153-8. PubMed ID: 11526199
[TBL] [Abstract][Full Text] [Related]
13. Systemic delivery of a Peptide-linked morpholino oligonucleotide neutralizes mutant RNA toxicity in a mouse model of myotonic dystrophy.
Leger AJ; Mosquea LM; Clayton NP; Wu IH; Weeden T; Nelson CA; Phillips L; Roberts E; Piepenhagen PA; Cheng SH; Wentworth BM
Nucleic Acid Ther; 2013 Apr; 23(2):109-17. PubMed ID: 23308382
[TBL] [Abstract][Full Text] [Related]
14. Myotonia and muscle contractile properties in mice with SIX5 deficiency.
Personius KE; Nautiyal J; Reddy S
Muscle Nerve; 2005 Apr; 31(4):503-5. PubMed ID: 15536612
[TBL] [Abstract][Full Text] [Related]
15. Mass spectrometry analysis of complexes formed by myotonic dystrophy protein kinase (DMPK).
Forner F; Furlan S; Salvatori S
Biochim Biophys Acta; 2010 Jun; 1804(6):1334-41. PubMed ID: 20188867
[TBL] [Abstract][Full Text] [Related]
16. A novel homeodomain-encoding gene is associated with a large CpG island interrupted by the myotonic dystrophy unstable (CTG)n repeat.
Boucher CA; King SK; Carey N; Krahe R; Winchester CL; Rahman S; Creavin T; Meghji P; Bailey ME; Chartier FL
Hum Mol Genet; 1995 Oct; 4(10):1919-25. PubMed ID: 8595416
[TBL] [Abstract][Full Text] [Related]
17. Myotonic dystrophy protein kinase (DMPK) gene expression in lymphocytes of patients with myotonic dystrophy.
Depardon F; Cisneros B; Alonso-Vilatela E; Montañez C
Arch Med Res; 2001; 32(2):123-8. PubMed ID: 11343809
[TBL] [Abstract][Full Text] [Related]
18. Progressive atrioventricular conduction block in a mouse myotonic dystrophy model.
Berul CI; Maguire CT; Gehrmann J; Reddy S
J Interv Card Electrophysiol; 2000 Jun; 4(2):351-8. PubMed ID: 10936001
[TBL] [Abstract][Full Text] [Related]
19. Characterization of cardiac conduction system abnormalities in mice with targeted disruption of Six5 gene.
Wakimoto H; Maguire CT; Sherwood MC; Vargas MM; Sarkar PS; Han J; Reddy S; Berul CI
J Interv Card Electrophysiol; 2002 Oct; 7(2):127-35. PubMed ID: 12397222
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1.
Hino S; Kondo S; Sekiya H; Saito A; Kanemoto S; Murakami T; Chihara K; Aoki Y; Nakamori M; Takahashi MP; Imaizumi K
Hum Mol Genet; 2007 Dec; 16(23):2834-43. PubMed ID: 17728322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
